Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study.
Marra G, Rajwa P, Filippini C, Ploussard G, Montefusco G, Puche-Sanz I, Olivier J, Zattoni F, Moro FD, Magli A, Dariane C, Affentranger A, Grogg JB, Hermanns T, Chiu PK, Malkiewicz B, Kowalczyk K, Van den Bergh RCN, Shariat SF, Bianchi A, Antonelli A, Gallina S, Berchiche W, Sanchez-Salas R, Cathelineau X, Afferi L, Fankhauser CD, Mattei A, Karnes RJ, Scuderi S, Montorsi F, Briganti A, Deandreis D, Gontero P, Gandaglia G; EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party (PCa-WP). Marra G, et al. Among authors: magli a. Clin Genitourin Cancer. 2024 Apr;22(2):244-251. doi: 10.1016/j.clgc.2023.11.006. Epub 2023 Nov 17. Clin Genitourin Cancer. 2024. PMID: 38155081 Free article.
Hypofractionated simultaneous integrated boost (IMRT-SIB) with pelvic nodal irradiation and concurrent androgen deprivation therapy for high-risk prostate cancer: results of a prospective phase II trial.
Magli A, Moretti E, Tullio A, Giannarini G, Tonetto F, Urpis M, Crespi M, Foti C, Prisco A, Polsinelli M, De Giorgi G, Bravo G, Scalchi P, Trovò M. Magli A, et al. Prostate Cancer Prostatic Dis. 2018 Jun;21(2):269-276. doi: 10.1038/s41391-018-0034-0. Epub 2018 Mar 8. Prostate Cancer Prostatic Dis. 2018. PMID: 29520019 Clinical Trial.
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
Zattoni F, Heidegger I, Kasivisvanathan V, Kretschmer A, Marra G, Magli A, Preisser F, Tilki D, Tsaur I, Valerio M, van den Bergh R, Kesch C, Ceci F, Fankhauser C, Gandaglia G. Zattoni F, et al. Among authors: magli a. Front Surg. 2021 Jul 9;8:691473. doi: 10.3389/fsurg.2021.691473. eCollection 2021. Front Surg. 2021. PMID: 34307443 Free PMC article. Review.
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques.
Tonetto F, Magli A, Moretti E, Guerini AE, Tullio A, Reverberi C, Ceschia T, Spiazzi L, Titone F, Prisco A, Signor MA, Buglione M, De Giorgi G, Trovò M, Triggiani L. Tonetto F, et al. Among authors: magli a. J Clin Med. 2022 Nov 23;11(23):6913. doi: 10.3390/jcm11236913. J Clin Med. 2022. PMID: 36498488 Free PMC article.
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study.
Preisser F, Abrams-Pompe RS, Stelwagen PJ, Böhmer D, Zattoni F, Magli A, Rivas JG, Dilme RV, Sepulcri M, Eguibar A, Heidegger I, Arnold C, Fankhauser CD, Chun FK, van der Poel H, Gandaglia G, Wiegel T, van den Bergh RCN, Tilki D; EAU-YAU Prostate Cancer Working Group. Preisser F, et al. Among authors: magli a. Eur Urol. 2024 Feb;85(2):164-170. doi: 10.1016/j.eururo.2023.05.038. Epub 2023 Jun 22. Eur Urol. 2024. PMID: 37355358
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter Cohort.
Marra G, Lesma F, Montefusco G, Filippini C, Olivier J, Affentranger A, Grogg JB, Hermanns T, Afferi L, Fankhauser CD, Mattei A, Malkiewicz B, Scuderi S, Barletta F, Gallina S, Antonelli A, Zattoni F, Dal Moro F, Lieke W, Soeterik T, van den Bergh RCN, Rajwa P, Shariat SF, Rodriguez-Sanchez L, Nicoletti R, Campi R, Ahmed M, Jeffrey Karnes R, Ladurner M, Heidegger I, Briganti A, Gontero P, Gandaglia G; Young Academic Urologists Prostate Cancer Working Group. Marra G, et al. Eur Urol Open Sci. 2024 Aug 22;68:32-39. doi: 10.1016/j.euros.2024.06.016. eCollection 2024 Oct. Eur Urol Open Sci. 2024. PMID: 39263349 Free PMC article.
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study.
Triggiani L, Alongi F, Buglione M, Detti B, Santoni R, Bruni A, Maranzano E, Lohr F, D'Angelillo R, Magli A, Bonetta A, Mazzola R, Pasinetti N, Francolini G, Ingrosso G, Trippa F, Fersino S, Borghetti P, Ghirardelli P, Magrini SM. Triggiani L, et al. Among authors: magli a. Br J Cancer. 2017 Jun 6;116(12):1520-1525. doi: 10.1038/bjc.2017.103. Epub 2017 Apr 27. Br J Cancer. 2017. PMID: 28449007 Free PMC article.
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation.
Cozzarini C, Olivieri M, Magli A, Cante D, Noris Chiorda B, Munoz F, Faiella A, Olivetta E, Deantoni C, Fodor A, Signor MA, Petrucci E, Avuzzi B, Ferella L, Pastorino A, Garibaldi E, Gatti M, Rago L, Statuto T, Rancati T, Briganti A, Montorsi F, Valdagni R, Sanguineti G, Di Muzio NG, Fiorino C. Cozzarini C, et al. Among authors: magli a. Radiother Oncol. 2022 Oct;175:26-32. doi: 10.1016/j.radonc.2022.08.001. Epub 2022 Aug 4. Radiother Oncol. 2022. PMID: 35934169
192 results